mRNA-3927

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for mRNA-3927, covering 2026-01-22 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study [Phase 1, Phase 2]

See pricing